Hainan Expressway Co., Ltd. (SHE:000886)

Verve Therapeutics Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 4, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	6,655	7,683	4,054	4,796	3,926	4,825
Market Cap Growth	35.16%	89.51%	-15.46%	22.17%	-18.65%	17.31%
Enterprise Value	6,598	7,230	2,663	3,143	2,431	3,032
Last Close Price	6.73	7.77	4.04	4.73	3.83	4.66
PE Ratio	492.52	124.92	44.79	19.17	76.41	52.02
Forward PE	-	9.94	9.94	9.94	9.94	9.94
PS Ratio	24.50	33.01	32.65	28.35	30.95	40.13
PB Ratio	2.18	2.50	1.33	1.58	1.39	1.70
P/TBV Ratio	2.28	2.62	1.37	1.65	1.44	1.77
EV/Sales Ratio	24.29	31.06	21.45	18.58	19.17	25.21
EV/FCF Ratio	-10.12	-	-	-	-	-
Debt / Equity Ratio	0.13	0.06	0.01	0.00	0.00	-
Asset Turnover	0.08	0.06	0.04	0.05	0.04	0.04
Inventory Turnover	0.29	0.25	0.19	0.20	0.07	0.07
Quick Ratio	1.80	1.45	3.96	5.66	5.96	4.60
Current Ratio	4.53	3.34	5.78	6.93	7.37	5.84
Return on Equity (ROE)	0.42%	2.01%	2.96%	8.52%	1.81%	3.29%
Return on Assets (ROA)	-1.73%	-1.69%	-1.79%	-1.31%	-1.01%	-0.55%
Return on Capital (ROIC)	-1.91%	-1.95%	-2.00%	-1.46%	-1.14%	-0.64%
Earnings Yield	0.20%	0.80%	2.23%	5.22%	1.31%	1.92%
FCF Yield	-9.79%	-9.94%	-9.94%	-3.88%	-4.30%	-3.31%
Dividend Yield	0.30%	0.26%	1.24%	1.06%	1.31%	2.15%
Payout Ratio	535.75%	114.40%	54.44%	19.63%	96.95%	52.86%
Buyback Yield / Dilution	-1.88%	-0.83%	1.69%	2.61%	0.30%	0.84%
Total Shareholder Return	-1.58%	-0.58%	2.92%	3.67%	1.61%	2.99%

Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.